- Pacira Pharmaceuticals (NASDAQ:PCRX): Q3 EPS of $0.14 beats by $0.04.
- Revenue of $52.05M (+123.8% Y/Y) misses by $0.15M.
- Press Release
Pacira Pharmaceuticals beats by $0.04, misses on revenue
Recommended For You
About PCRX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| PCRX | - | - |
| Pacira BioSciences, Inc. | ||